Clinical trial
Combination Chemotherapy in Treating Patients With Stage III Colon Cancer
NCT00003835 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00003835 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Stage III Colon Cancer |
| Official title | Phase III Intergroup Trial of Irinotecan (CPT-11) (NSC# 616348) Plus Fluorouracil/Leucovorin (5-FU/LV) Versus Fluorouracil/Leucovorin Alone After Curative Resection for Patients With Stage III Colon Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | SWOG Cancer Research Network North Central Cancer Treatment Group Eastern Cooperative Oncology Group NCIC Clinical Trials Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Adenocarcinoma of the Colon, Stage III Colon Cancer |
| Intervention type | Drug, Other |
| Interventions | leucovorin calcium, fluorouracil, irinotecan hydrochloride, laboratory biomarker analysis |
| Enrollment | 1,260 |
| Start date | May 1, 1999 |
| Primary completion | Aug 1, 2007 |
| First posted | Apr 27, 2004 |
| Last update posted | Oct 8, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: